Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. AusCann Group Holdings Ltd
  6. News
  7. Summary
    AC8   AU000000AC89

AUSCANN GROUP HOLDINGS LTD

(AC8)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

AusCann Group Holdings (ASX:AC8) talks cannabis market in Australia

09/18/2017 | 12:10am EDT

AusCann Group Holdings (ASX:AC8), Managing Director Elaine Darby, talks plan for the year ahead and potential market size in Australia.


AusCann Group Holdings (ASX:AC8) aims to bring Australian patients access to high quality, cost effective, cannabinoid medicines.

Market size / potential in Australia is with chronic (3.8M patients) & neuropathic pain sufferers (1.8M patients). Cannabinoid medicines offer many benefits including a reduction in side effects / opiates.

Challenges to its use include education of Australian Medical Community and AusCann are using the Canadian Market as blueprint.
- Canadian expert Dr Daniel Schecter appointed Chief Medical Advisor
- Medical outreach program
- Liaison Managers
- Mentorship program
- Online courses

In Canada, the market has grown from 8000 patients in 2014 with its introduction to 170k+ patients in 2017 and is projected to increase to over 500k+ patients projected by 2021

Focus for the year ahead: Importing Canadian product from Canadian company Canopy Growth Corp, increasing understanding of the benefits among Australian Doctors and increasing its prescription, application for Australian licences to grow local product.
Copyright 2017 - Finance News Network


ę Financenewsnetwork 2017
Stocks mentioned in the article
ChangeLast1st jan.
ASX LIMITED -0.27% 81.36 End-of-day quote.13.00%
AUSCANN GROUP HOLDINGS LTD 4.76% 0.11 End-of-day quote.-43.59%
CRONOS GROUP INC. -1.01% 6.89 Delayed Quote.-22.06%
HEXO CORP. -0.47% 2.1 Delayed Quote.1,254.84%
LETS HOLDINGS GROUP CO., LTD. -3.33% 6.1 End-of-day quote.-21.59%
LOOK HOLDINGS INCORPORATED 0.66% 1375 End-of-day quote.43.68%
ORGANIGRAM HOLDINGS INC. 1.05% 2.9 Delayed Quote.71.60%
All news about AUSCANN GROUP HOLDINGS LTD
10/18AUSCANN : Files Formal Meeting Request with US FDA Related to Veterinary Drug
MT
10/12AUSCANN : Completes Dose Tolerance Study, Files Registrations for Veterinary Product
MT
10/12AusCann Group Holdings Ltd Completes US Safety Study for Dermacann Registration
CI
09/20AUSCANN : Appoints Data, Asset Reviewer to Accelerate Development of Cannabinoid-based Dru..
MT
09/09Auscann Group Taps US Consultant to Advance Cannabis Drug Candidate in US
MT
08/29Auscann Group Holdings Ltd Reports Earnings Results for the Full Year Ended June 30, 20..
CI
07/19AUSCANN : Starts Australian Product Registration for Anti-Inflammatory Product for Dog Ski..
MT
07/19AusCann Group Holdings Limited Commences Australian Product Registration for Dogs
CI
07/01Auscann Secures Medical Cannabis Supply Deal with Tasmanian Department of Health
MT
06/17AUSCANN : Leases R&D Facility for Initial Five-Year Term
MT
More news
Financials
Sales 2021 1,80 M 1,35 M 1,35 M
Net income 2021 -8,64 M -6,48 M -6,48 M
Net cash 2021 13,8 M 10,3 M 10,3 M
P/E ratio 2021 -4,04x
Yield 2021 -
Capitalization 48,5 M 36,3 M 36,3 M
EV / Sales 2020 19,5x
EV / Sales 2021 16,6x
Nbr of Employees -
Free-Float 93,4%
Chart AUSCANN GROUP HOLDINGS LTD
Duration : Period :
AusCann Group Holdings Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AUSCANN GROUP HOLDINGS LTD
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Managers and Directors
Layton Patrick Mills Chief Executive Officer
Charles Altshuler Chief Financial Officer & Head-Supply
Robert Maxwell Johnston Chairman
Melinda Thompson Director-Research & Regulatory Affairs
Maria Alexakis Director-Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
AUSCANN GROUP HOLDINGS LTD-43.59%36
JOHNSON & JOHNSON4.26%431 938
ROCHE HOLDING AG15.61%338 364
NOVO NORDISK A/S59.69%243 351
PFIZER, INC.17.25%241 929
ELI LILLY AND COMPANY45.14%222 158